SecBot SecBot
144 ·Filed Nov 12, 2026

GILD

GILEAD SCIENCES, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 5h ago SEC0001950047-26-011039
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine Form 144 filing by a director. The sale amount is small relative to Gilead's market cap. No material impact expected. Monitor for any subsequent Form 4 filings to confirm execution.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$168.08
T+0 close · Nov 12, 2026 · via day close
Latest settled
−0.30%
T+1 · $167.58
Vs SPY
+1.61%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $168.08entry
  2. T+1 · 15h ago −0.30%α +1.61% · $167.58
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Kelly Kramer filed a Form 144 notice of intent to sell 10,376 shares of Gilead Sciences common stock, with an estimated aggregate market value of approximately $1.76 million. The shares were acquired through exercise of stock options on the same day as the filing. The sale represents a routine insider transaction by a director and is not material relative to Gilead's market cap.

Key Facts

  • Reporting person: Kelly A. Kramer, Director of Gilead Sciences
  • Proposed sale of 10,376 shares of common stock
  • Estimated aggregate market value: $1,761,118.48
  • Shares acquired via exercise of stock options on 2026-11-12
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  • Sale intended to be executed on NASDAQ

Financial Impact

Approximately $1.76 million, representing a small fraction of the director's holdings and a negligible percentage of Gilead's market cap.

dilution

Risk Factors

  • Insider selling could be perceived negatively if it precedes negative news, but no such context is present here.
  • The sale may not occur; Form 144 is an intent to sell.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-011039
Document: 0001950047-26-011039-index.html0001950047-26-011039
Document: 0001950047-26-011039.txt0001950047-26-011039

Track record

30 reports on GILD

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
  2. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
  3. Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
  4. Nov 12, 20264d ago 144 Neutral 2/10 Viewing Entry $168.08 Now $167.58 −0.30% settles Feb 11
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
  6. Nov 6, 202610d ago 144 Neutral 2/10 Entry $169.32 Now $167.58 −1.03% settles Feb 5
  7. Nov 4, 202612d ago 144 Neutral 3/10 Entry $167.57 Now $167.58 +0.01% settles Feb 3
  8. Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
  9. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
  10. Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (11h 32m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026